TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD和其他2只股票每股低于2美元，高管都在购买
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周五收盘上涨了450点以上。当内部人士购买或出售股票时，这表明他们对公司前景的信心或关切。对于对低价股感兴趣的投资者和交易员，他们可以将这视为其整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是几个近期关于低价股的值得关注的内部交易。了解更多，请查看Benzinga内幕交易平台。
System1
System1
- The Trade: System1, Inc. (NYSE:SST) 10% owner Cee Holdings Trust bought a total of 46,373 shares at an average price of $1.22. To acquire these shares, it cost around $56,378.
- What's Happening: On Aug. 8, System1 posted upbeat quarterly earnings.
- What System1 Does: System1 Inc develops technology and data science to operate a responsive acquisition marketing platform.
- 交易：System1, Inc. (纽交所:SST) 10%持有人Cee Holdings Trust以平均价格1.22美元购入46373股。购入这些股票，成本约为56378美元。
- 正在发生什么：8月8日，System1发布了乐观的季度收益报告。
- System1 Inc开发技术和数据科学，以运营响应式收购营销平台。
TherapeuticsMD
therapeuticsmd
- The Trade: TherapeuticsMD, Inc. (NASDAQ:TXMD) Director Cooper C. Collins acquired a total of 1,200 shares at an average price of $1.70. To acquire these shares, it cost around $2,039.
- What's Happening: On Aug. 12, TherapeuticsMD posted a second-quarter loss of 9 cents per share.
- What TherapeuticsMD Does: TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories.
- 交易：therapeuticsmd, Inc. (纳斯达克:TXMD) 董事Cooper C. Collins以平均价格1.70美元获得1200股。购入这些股票，成本约为2039美元。
- 最新动态：therapeuticsmd在8月12日公布，每股亏损9美分。
- therapeuticsmd的业务：therapeuticsmd公司是一家药品特许权公司，目前正在从在相关领域具有商业能力的药品机构许可的产品上获取特许权。
Ault Alliance
奥特联盟
- The Trade: Ault Alliance, Inc. (NYSE:AULT) Executive Chairman Milton C Ault III acquired a total of 2,800 shares at an average price of $0.23. The insider spent around $655 to buy those shares.
- What's Happening: On Aug. 20, Ault Alliance declared a monthly cash dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock.
- What Ault Alliance Does: Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles.
- 交易：Ault Alliance, Inc.（NYSE:AULT）执行主席Milton C Ault III以0.23美元的平均价购入2800股，花费大约655美元购买了这些股票。
- 最新动态：8月20日，Ault Alliance宣布每股13.00%D系列可赎回永续优先股的月度现金股息为0.2708333美元。
- Ault Alliance的业务：Ault Alliance Inc是一家多元化控股公司。其在一个数据中心运营，用于挖掘比特币，并提供支持多个行业的关键产品，包括石油勘探、起重服务、军工/航空航天、工业、汽车、医疗/生物制药、消费电子、酒店运营和纺织品。
- Jim Cramer Praises L3Harris Technologies, Says Intel Is 'Getting Whacked' By AMD: 'I Much Prefer...'
- 吉姆·克雷默赞扬L3Harris Technologies，并表示英特尔（Intel）正受到AMD的打击：'我更喜欢……'
资讯热榜
更新时间